It took Virginia Cancer Specialists nearly 1 year to get the supervised case experience needed to fulfill regulation ...

For many women in the United States who encounter drenching night sweats, sudden hot flashes, debilitating exhaustion and ...

Hematological malignancies encompass a diverse range of diseases, such as leukemia, lymphoma, and multiple myeloma, among others. Within the multidisciplinary treatment approach, radiation therapy ...

Determining the best MLB player at each position is no easy exercise, and the results of the number-crunching will never please everyone. But the debate is all part of the fun. We find ourselves in ...

Survivorship is a relational shift for the whole family, not a return to pre-cancer life. Fear of recurrence affects the ...

NCCN updates recommend cabozantinib for neuroendocrine tumors, offering flexibility in treatment options based on patient needs and prior therapies. This segment focuses on systemic treatment ...

Anti–PD-1 therapy (pembrolizumab, nivolumab) supports neoadjuvant and adjuvant management of higher-risk melanoma, offering durable remissions with less systemic toxicity than traditional chemotherapy ...

Oncologists are increasingly reaching for the prescription pad before the scalpel, driving a dramatic rise in the use of neoadjuvant therapy for solid tumors, according to new research. The second ...

A new study exploring the investigational therapy, Zorpo-cel, met its primary safety and secondary efficacy endpoints in people with progressive and treatment-resistant systemic sclerosis (SSc), ...

Systemic embolic events (SEEs) are a serious but underrecognized complication of atrial fibrillation. Although non–vitamin K antagonist oral anticoagulants prevent ischemic stroke (IS), their efficacy ...

The trial evaluates survival outcomes for recurrent head and neck squamous cell carcinoma post-radiation therapy, comparing surgery alone to neoadjuvant chemotherapy with or without immunotherapy.